Medical Policy and Coding Updates - October 2022
Summary
Effective December 1, 2022, botulinum toxin codes J0585, J0586, J0587 and J0588 require medical necessity review and prior authorization. Effective October 1, 2022, AIM Specialty Health genetic testing codes such as 0332U through 0350U are reviewed by AIM Specialty Health and require prior authorization, and codes Q2056, J1302, J9274, Q5125 and J2777 now require medical necessity review and prior authorization. Effective January 6, 2023, electroconvulsive therapy (ECT) and total ankle replacement are reviewed under InterQual criteria, and code 90870 now requires medical necessity review and prior authorization.
Get alerts when payers change rules like this one
We check Premera Blue Cross and other payers every day and email you when a change matches your specialty and state.